SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-016937
Filing Date
2020-06-17
Accepted
2020-06-17 20:55:52
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4195
  Complete submission text file 0000899243-20-016937.txt   5673
Mailing Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121 (858) 412-8400
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTE BIOSCIENCES, INC. 1124 W. CARSON ST., MRL BLDG 3-320 TORRANCE CA 90502
Business Address
Kornfeld Steven (Reporting) CIK: 0001814653 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 20971071